SyGoBioClin SRL
SyGoBioClin reported total assets of 235,248 € at the end of the 2025 financial year (annual accounts filed with the NBB on 22 May 2026).
The score of SyGoBioClin shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -97 % Total assets +13 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
SyGoBioClin's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 41,654 € | ||||
| Equity | 5,500 € | ||||
| Cash | 225,296 € | ||||
| EBITDA | 55,648 € | ||||
| Total assets | 235,248 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 May 2026
- Year ended 31 Dec 2024filed on 02 Sep 2025
- Year ended 31 Dec 2023filed on 23 Aug 2024
- Year ended 31 Dec 2022filed on 24 Aug 2023
- Year ended 31 Dec 2021filed on 27 Jun 2022
SyGoBioClin's financial analysis
- Solvency2.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of SyGoBioClin
SyGoBioClin's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0734.974.146
- VAT number
- BE0734974146
- Peppol
- Registered · 0208:0734974146 · as of 11 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Sep 2019
- Registered office
- 1950 Kraainem
- Latest accounts
- 2025 · filed on 22 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
SyGoBioClin (SRL) has been based in Kraainem since 2019, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 41,654 € and equity of 5,500 €; its revenue is not published. Its solvency stands at 2.3%, below the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to SyGoBioClin
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Keereman Retail sale of pharmaceutical products Schaerbeek · balance sheet 235,291 €
- DVL Retail sale of pharmaceutical products Dilbeek · balance sheet 235,408 €
- Apoteek de Decker Retail sale of pharmaceutical products Lebbeke · balance sheet 234,587 €
- Lorophar Retail sale of pharmaceutical products Lincent · balance sheet 234,299 €
- Elapharma Retail sale of pharmaceutical products Brussels · balance sheet 236,353 €
- Apotheek van Hoecke Retail sale of pharmaceutical products Kortrijk · balance sheet 234,019 €
- Pharmaphie EVG Retail sale of pharmaceutical products Evergem · balance sheet 229,312 €
- Sapos Retail sale of pharmaceutical products Aalst · balance sheet 241,792 €
Frequently asked questions about SyGoBioClin
What is the revenue of SyGoBioClin?
SyGoBioClin files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of SyGoBioClin?
In Belgium, the VAT number is the company number prefixed with BE: BE0734974146 for SyGoBioClin, if the company is VAT-registered. Its company number (CBE) is 0734.974.146.
Where is the registered office of SyGoBioClin?
According to the CBE register, the registered office of SyGoBioClin is in 1950 Kraainem.
What is the equity of SyGoBioClin?
At the close of the 2025 financial year, the equity of SyGoBioClin amounts to 5,500 €, a solvency of 2.3% of total assets.
Who manages SyGoBioClin?
The register lists 1 active mandates at SyGoBioClin. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of SyGoBioClin
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →